The Brink's Company has announced modifications to its Severance Pay Plan and Change in Control Plan effective July 16, 2025, following approval by the Compensation and Human Capital Committee. Key changes include an increase in cash severance benefits for CEO Mark Eubanks in the event of a Qualifying Termination, from 1.5 to 2.0 times his annual salary and target annual incentive opportunity, and an extension of continued equity award vesting benefits from 12 to 24 months post-termination. Additionally, performance-based vesting conditions for equity awards will now be based on actual performance instead of the lower of target or actual performance. The Change in Control Plan amendments raise the cash severance benefit for the CEO from 2.0 to 3.0 times his annual salary and three-year average actual bonus, and extend the COBRA healthcare continuation benefit from 18 to 24 months. These adjustments aim to enhance termination protections and retention value for the CEO and participating executives.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.